Spectrofluorometric determination of captopril plus captopril disulfide metabolites in plasma.
E Ivashkiv
Index: J. Pharm. Sci. 73(10) , 1427-30, (1984)
Full Text: HTML
Abstract
Captopril disulfides and the drug covalently bound to proteins were reduced with tri-n-butylphosphine. After sample purification on an XAD-2 column, captopril was treated with 1-(7-dimethylamino)-4-methyl-2-oxo-2H -1-benzopyran-3-yl)-1H-pyrrole-2,5-dione to form a fluorescent derivative. After acidification, the fluorescent derivative was extracted into toluene and purified on a C18 cartridge. The fluorescence of the dimethyl-formamide eluate was measured at an excitation wavelength of 380 nm and a fluorescence wavelength of 440 nm.
Related Compounds
Related Articles:
1984-11-15
[Biochem. Pharmacol. 33(22) , 3567-71, (1984)]
1987-01-01
[Eur. J. Clin. Pharmacol. 32(3) , 267-71, (1987)]
1998-08-01
[Yao Xue Xue Bao 33(8) , 605-9, (1998)]
1988-08-09
[Eur. J. Pharmacol. 153(1) , 11-7, (1988)]
2012-08-01
[Chemosphere 88(10) , 1170-7, (2012)]